These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19268726)

  • 21. Practice patterns for surveillance of Barrett's esophagus in the united states.
    Falk GW; Ours TM; Richter JE
    Gastrointest Endosc; 2000 Aug; 52(2):197-203. PubMed ID: 10922091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Audit of a Barrett's epithelium surveillance database.
    Basu KK; Pick B; de Caestecker JS
    Eur J Gastroenterol Hepatol; 2004 Feb; 16(2):171-5. PubMed ID: 15075990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
    Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
    Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to Surveillance Guidelines in Nondysplastic Barrett's Esophagus.
    Dalal KS; Coffing J; Imperiale TF
    J Clin Gastroenterol; 2018 Mar; 52(3):217-222. PubMed ID: 27984402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
    Cameron AJ; Carpenter HA
    Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.
    Reid BJ; Blount PL; Feng Z; Levine DS
    Am J Gastroenterol; 2000 Nov; 95(11):3089-96. PubMed ID: 11095322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett's esophagus: a prospective, double-blinded study.
    Isenberg G; Sivak MV; Chak A; Wong RC; Willis JE; Wolf B; Rowland DY; Das A; Rollins A
    Gastrointest Endosc; 2005 Dec; 62(6):825-31. PubMed ID: 16301020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma.
    Hillman LC; Chiragakis L; Clarke AC; Kaushik SP; Kaye GL
    J Gastroenterol Hepatol; 2003 May; 18(5):526-33. PubMed ID: 12702044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of confocal laser endomicroscopy in identifying high-grade dysplasia and adenocarcinoma in Barrett's esophagus: a systematic review and meta-analysis.
    Gupta A; Attar BM; Koduru P; Murali AR; Go BT; Agarwal R
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):369-77. PubMed ID: 24535597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SAGES TAVAC safety and efficacy analysis WATS
    Docimo S; Al-Mansour M; Tsuda S
    Surg Endosc; 2020 Sep; 34(9):3743-3747. PubMed ID: 32162125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of dysplastic and neoplastic progression of Barrett’s esophagus.
    Alnasser S; Agnihotram R; Martel M; Mayrand S; Franco E; Ferri L
    Can J Surg; 2019 Apr; 62(2):93-99. PubMed ID: 30907564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus.
    van der Wel MJ; Klaver E; Duits LC; Pouw RE; Seldenrijk CA; Offerhaus G; Visser M; Ten Kate F; Biermann K; Brosens L; Doukas M; Huysentruyt C; Karrenbeld A; Kats-Ugurlu G; van der Laan JS; van Lijnschoten G; Moll F; Ooms A; Tijssen JG; Bergman J; Meijer SL
    United European Gastroenterol J; 2019 Aug; 7(7):889-896. PubMed ID: 31428413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopy in Barrett's oesophagus: adherence to standards and neoplasia detection in the community practice versus hospital setting.
    Pohl H; Aschenbeck J; Drossel R; Schröder A; Mayr M; Koch M; Rothe K; Anders M; Voderholzer W; Hoffmann J; Schulz HJ; Liehr RM; Gottschalk U; Wiedenmann B; Rösch T
    J Intern Med; 2008 Oct; 264(4):370-8. PubMed ID: 18482289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dedicated Barrett's surveillance sessions managed by trained endoscopists improve dysplasia detection rate.
    Ooi J; Wilson P; Walker G; Blaker P; DeMartino S; O'Donohue J; Reffitt D; Lanaspre E; Chang F; Meenan J; Dunn JM
    Endoscopy; 2017 Jun; 49(6):524-528. PubMed ID: 28399610
    [No Abstract]   [Full Text] [Related]  

  • 36. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia.
    Falk GW; Rice TW; Goldblum JR; Richter JE
    Gastrointest Endosc; 1999 Feb; 49(2):170-6. PubMed ID: 9925694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus.
    Ragunath K; Krasner N; Raman VS; Haqqani MT; Cheung WY
    Endoscopy; 2003 Dec; 35(12):998-1003. PubMed ID: 14648410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification for malignant progression in Barrett's esophagus: Gender, age, duration and year of surveillance.
    Gatenby P; Bhattacharjee S; Wall C; Caygill C; Watson A
    World J Gastroenterol; 2016 Dec; 22(48):10592-10600. PubMed ID: 28082811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.